KETARIZO, created in 2005 (Switzerland), from 19 sister brands and 2214 competing brands. The KETARIZO brand is owned by BASILEA PHARMA, a company listed in Zurich. The International Securities Identification Number (ISIN) of BASILEA PHARMA is CH0011432447. KETARIZO is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
BASILEA PHARMA
(KETARIZO)
over 5 years*
CHF 30.46